McIlrath & Eck, LLC
- SEC CIK
- 0001701714
- Latest filing
- May 19, 2026
SNY holding history
Sanofi in every 13F filed by McIlrath & Eck, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SNY overviewAll 13F holders of SNYFull Q1 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −966−100.0% | Sold out | Holders |
| Q1 2024 | 966 | $46.9K | <0.1% | +353+57.6% | Added | Holders |
| Q4 2023 | 613 | $30.5K | <0.1% | +361+143.3% | Added | Holders |
| Q3 2023 | 252 | $13.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 252 | $13.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 252 | $13.7K | <0.1% | +252 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −270−100.0% | Sold out | Holders |
| Q1 2022 | 270 | $14.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 270 | $14.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 270 | $13.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 270 | $14.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 270 | $13.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.